Rajiv Sood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rajiv Sood has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aleksa Jovanovic
Smith & Nephew Plc., Fort Worth, TX 76107, USA
1 shared publication - Alfredo Cordova
Department of Emergency General Surgery, Trauma, Critical Care and Burns, Memorial Hospital, Sarasota FL 34239, USA, USA
1 shared publication - Ariel Aballay
Allegheny General Hospital, Pittsburgh PA 15212, USA, USA
1 shared publication - Carrie Ann PA-C McGroarty
Department of Plastic and Reconstructive Surgery, WakeMed Health and Hospitals , Raleigh, NC 27610
1 shared publication - John Lantis Ii
Department of Surgery, Mount Sinai Hospital, New York, NY, US
1 shared publication - Marcus Yarbrough
Alpha Wound and Burn Care, Virginia Beach VA 23462, USA, USA
1 shared publication
Latest Publications
- Open Access
- 15 October 2025
- Published by MDPI AG in Preprints.org
Consensus Recommendations for Intact Fish Skin Graft in the Management of Burn Injury
Background: Intact fish skin graft (IFSG) derived from North Atlantic cod emerged as a treatment for burns in 2019. This consensus paper presents the best to date evidence and experience-based recommendations from eight U.S. burn care experts regarding optimal use of IFSG across different burn depths and wound types. Methods: Eight U.S. burn specialists with routine IFSG experience conducted a two cycle modified Nominal Focus Group. A systematic literature search (through April 2024) was conducted, followed by informed discussion, and the generation of consensus statements. Consensus was defined as ≥80 % agreement on a 5 point Likert scale. Results: Full or strong consensus (≥80 %) was reached on 12/15 statements. IFSG is recommended for: mid-dermal & deep-dermal partial-thickness burns (as definitive treatment), full thickness traumatic & burn wounds (in a 2-stage procedure before split-thickness skin graft). IFSG is not routinely recommended for purely epidermal burns. Based on recommendations from panelists, IFSG should be applied immediately after thorough debridement except in traumatic wounds when IFSG application should be delayed until clear demarcation and resolution of any infection. Reapplication is rarely required and, if needed, should occur 6–10 days after the initial graft. For wounds >100 cm², negative pressure wound therapy (NPWT) is the preferred bolster. The panel agreed IFSG accelerates readiness for STSG, decreases procedural pain, and can reduce nursing burden and overall cost of care. Recommendations: Clinicians should reserve IFSG for deep-dermal or full thickness burns and traumatic wounds and should pair IFSG with NPWT for large areas. IFSG is not needed in superficial burns that heal adequately with standard care. Prospective trials in deep-dermal partial thickness and full thickness burns remain a priority.
- 15 October 2025
- Published by MDPI AG in Preprints.org
Open AccessConsensus Recommendations for Intact Fish Skin Graft in the Management of Burn Injury
Background: Intact fish skin graft (IFSG) derived from North Atlantic cod emerged as a treatment for burns in 2019. This consensus paper presents the best to date evidence and experience-based recommendations from eight U.S. burn care experts regarding optimal use of IFSG across different burn depths and wound types. Methods: Eight U.S. burn specialists with routine IFSG experience conducted a two cycle modified Nominal Focus Group. A systematic literature search (through April 2024) was conducted, followed by informed discussion, and the generation of consensus statements. Consensus was defined as ≥80 % agreement on a 5 point Likert scale. Results: Full or strong consensus (≥80 %) was reached on 12/15 statements. IFSG is recommended for: mid-dermal & deep-dermal partial-thickness burns (as definitive treatment), full thickness traumatic & burn wounds (in a 2-stage procedure before split-thickness skin graft). IFSG is not routinely recommended for purely epidermal burns. Based on recommendations from panelists, IFSG should be applied immediately after thorough debridement except in traumatic wounds when IFSG application should be delayed until clear demarcation and resolution of any infection. Reapplication is rarely required and, if needed, should occur 6–10 days after the initial graft. For wounds >100 cm², negative pressure wound therapy (NPWT) is the preferred bolster. The panel agreed IFSG accelerates readiness for STSG, decreases procedural pain, and can reduce nursing burden and overall cost of care. Recommendations: Clinicians should reserve IFSG for deep-dermal or full thickness burns and traumatic wounds and should pair IFSG with NPWT for large areas. IFSG is not needed in superficial burns that heal adequately with standard care. Prospective trials in deep-dermal partial thickness and full thickness burns remain a priority.
- Open Access
- 11 August 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (16) , 8643
Clostridium Collagenase Impact on Zone of Stasis Stabilization and Transition to Healthy Tissue in Burns
Clostridium collagenase has provided superior clinical results in achieving digestion of immediate and accumulating devitalized collagen tissue. Recent studies suggest that debridement via Clostridium collagenase modulates a cellular response to foster an anti-inflammatory microenvironment milieu, allowing for a more coordinated healing response. In an effort to better understand its role in burn wounds, we evaluated Clostridium collagenase’s ability to effectively minimize burn progression using the classic burn comb model in pigs. Following burn injury, wounds were treated with Clostridium collagenase or control vehicle daily and biopsied at various time points. Biopsies were evaluated for factors associated with progressing necrosis as well as inflammatory response associated with treatment. Data presented herein showed that Clostridium collagenase treatment prevented destruction of dermal collagen. Additionally, treatment with collagenase reduced necrosis (HMGB1) and apoptosis (CC3a) early in burn injuries, allowing for increased infiltration of cells and protecting tissue from conversion. Furthermore, early epidermal separation and epidermal loss with a clearly defined basement membrane was observed in the treated wounds. We also show that collagenase treatment provided an early and improved inflammatory response followed by faster resolution in neutrophils. In assessing the inflammatory response, collagenase-treated wounds exhibited significantly greater neutrophil influx at day 1, with macrophage recruitment throughout days 2 and 4. In further evaluation, macrophage polarization to MHC II and vascular network maintenance were significantly increased in collagenase-treated wounds, indicative of a pro-resolving macrophage environment. Taken together, these data validate the impact of clostridial collagenases in the pathophysiology of burn wounds and that they complement patient outcomes in the clinical scenario.
- 11 August 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (16) , 8643
Open AccessClostridium Collagenase Impact on Zone of Stasis Stabilization and Transition to Healthy Tissue in Burns
Clostridium collagenase has provided superior clinical results in achieving digestion of immediate and accumulating devitalized collagen tissue. Recent studies suggest that debridement via Clostridium collagenase modulates a cellular response to foster an anti-inflammatory microenvironment milieu, allowing for a more coordinated healing response. In an effort to better understand its role in burn wounds, we evaluated Clostridium collagenase’s ability to effectively minimize burn progression using the classic burn comb model in pigs. Following burn injury, wounds were treated with Clostridium collagenase or control vehicle daily and biopsied at various time points. Biopsies were evaluated for factors associated with progressing necrosis as well as inflammatory response associated with treatment. Data presented herein showed that Clostridium collagenase treatment prevented destruction of dermal collagen. Additionally, treatment with collagenase reduced necrosis (HMGB1) and apoptosis (CC3a) early in burn injuries, allowing for increased infiltration of cells and protecting tissue from conversion. Furthermore, early epidermal separation and epidermal loss with a clearly defined basement membrane was observed in the treated wounds. We also show that collagenase treatment provided an early and improved inflammatory response followed by faster resolution in neutrophils. In assessing the inflammatory response, collagenase-treated wounds exhibited significantly greater neutrophil influx at day 1, with macrophage recruitment throughout days 2 and 4. In further evaluation, macrophage polarization to MHC II and vascular network maintenance were significantly increased in collagenase-treated wounds, indicative of a pro-resolving macrophage environment. Taken together, these data validate the impact of clostridial collagenases in the pathophysiology of burn wounds and that they complement patient outcomes in the clinical scenario.